HPCM
AMGN icon

High Pointe Capital Management’s Amgen AMGN Stock Holding History

High Pointe Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,150
Closed -$1.79M – 169
2014
Q2 		$1.79M Hold
15,150
– – 0.65% 83
2014
Q1 		$1.87M Hold
15,150
– – 0.72% 69
2013
Q4 		$1.73M Sell
15,150
-3,850
-20% -$438K 0.68% 81
2013
Q3 		$2.13M Buy
19,000
+500
+3% +$54.2K 0.85% 56
2013
Q2 		$1.82M Buy
+18,500
New +$1.92M 0.8% 62

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

High Pointe Capital Management's AMGN Position: Q3 2014 in Review

High Pointe Capital Management sold out of Amgen (AMGN) in Q3 2014, closing a stake of 15,150 shares — an estimated $1.79M sold.

High Pointe Capital Management first reported a position in AMGN in Q2 2013 and held it in 5 quarters. The position peaked at $2.13M in Q3 2013. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • High Pointe Capital Management reported no remaining Amgen position as of Q3 2014 after selling out during the quarter.
  • High Pointe Capital Management sold 15,150 Amgen shares in Q3 2014, an estimated $1.79M.
  • High Pointe Capital Management first reported a position in Amgen in Q2 2013 and held it in 5 quarters.
  • High Pointe Capital Management's Amgen position peaked at $2.13M in Q3 2013.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on High Pointe Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.